TMCnet News
Global Anti-Parkinson's Drugs Market 2018: Analysis & Forecasts (2013-2022) - Major Players Abbvie, Mylan Laboratories, Valeant Pharmaceuticals and Novartis are Profiled - ResearchAndMarkets.comThe "Anti-Parkinson's Drugs: Global Markets to 2022" report has been added to ResearchAndMarkets.com's offering. This research report categorizes the anti-Parkinson's drugs market by type. Product types include low dopaminergic, dopamine agonists, enzyme inhibitors and other anti-Parkinson's medications. This report includes:
Key Findings:
Key Topics Covered: 1 Introduction 2 Summary and Highlights 3 Anti-Parkinson's Drugs Market Characteristics 4 Anti-Parkinson's Drugs Market Size and Growth 5 Anti-Parkinson's Drugs Market Trends and Strategies 6 PESTLE Analysis 7 Anti-Parkinson's Drugs Market Segmentation 8 Anti-Parkinson's Drugs Market Regional and Country Analysis 9 Global Anti-Parkinson's Drugs Market Comparison with Macro Economic Factors 10 Asia-Pacific Anti-Parkinson's Drugs Market 11 Asia-Pacific Anti-Parkinson's Drugs Market: Country Analysis 12 Western Europe Anti-Parkinson's Drugs Market 13 Western Europe Anti-Parkinson's Drugs Market: Country Analysis 14 Eastern Europe Anti-Parkinson's Drugs Market 15 Eastern Europe Anti-Parkinson's Drugs Market: Country Analysis 16 North America Anti-Parkinson's Drugs Market 17 North America Anti-Parkinson's Drugs Market: Country Analysis 18 South America Anti-Parkinson's Drugs Market 19 South America Anti-Parkinson's Drugs Market: Country Analysis 20 Middle East Anti-Parkinson's Drugs Market 21 Africa Anti-Parkinson's Drugs Market 22 Anti-Parkinson's Drugs Market Customer Information 23 Anti-Parkinson's Drugs Market Competitive Landscape 24 Key Mergers and Acquisitions in the Anti-Parkinson's Drugs Market For more information about this report visit https://www.researchandmarkets.com/research/wz43xb/global?w=4 View source version on businesswire.com: http://www.businesswire.com/news/home/20180312005946/en/ |